ArticleJournal of cardiovascular development and disease2026
Comment on Iacobescu et al. Evaluating Binary Classifiers for Cardiovascular Disease Prediction: Enhancing Early Diagnostic Capabilities.
Article in Journal of cardiovascular development and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reply to Eltawil et al. Comment on "Iacobescu et al. Evaluating Binary Classifiers for Cardiovascular Disease Prediction: Enhancing Early Diagnostic Capabilities.Journal of cardiovascular development and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Machine learning is increasingly applied to cardiovascular disease prediction yet reported performance metrics often appear implausibly high due to methodological errors. Recent work has reported nearly perfect predictive accuracy (≈99%) using a k-Nearest Neighbors (kNN) model on CDC heart-disease data. Such performance greatly exceeds typical BRFSS-based benchmarks and strongly indicates data leakage. In this commentary, we replicate and re-analyze the original workflow, showing that the authors applied the SMOTE-ENN resampling method prior to the train/test split, thereby allowing synthetic data generated from the full dataset to contaminate the test set. Combined with an excessively small neighborhood parameter (k = 2), this produced misleadingly high accuracy. It is noted that (1) with SMOTE-ENN performed globally, synthetic samples appear nearly identical to test points, leading to near-perfect classification, and (2) this kNN choice is unusually small for a dataset of this scale and further amplifies leakage bias. Correcting the workflow by restricting oversampling to the training data or using undersampling restores realistic results, reducing predictive accuracy to approximately 80%, confirming the inflation caused by pre-split resampling and aligning with literature norms. This case underscores the critical importance of rigorous validation, transparent reporting, and leakage-free pipelines in medical AI. We outline practical guidelines for avoiding such pitfalls and ensuring reproducible, realistic, and clinically reliable machine-learning studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.